CS228431B1 - Process for separating of optic isomers of phenylalaninederivates being substituted in p-position - Google Patents
Process for separating of optic isomers of phenylalaninederivates being substituted in p-position Download PDFInfo
- Publication number
- CS228431B1 CS228431B1 CS318682A CS318682A CS228431B1 CS 228431 B1 CS228431 B1 CS 228431B1 CS 318682 A CS318682 A CS 318682A CS 318682 A CS318682 A CS 318682A CS 228431 B1 CS228431 B1 CS 228431B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- phenylalanine
- ethylphenylalanine
- phenylacetyl
- substituted
- phenylalaninederivates
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 9
- 230000003287 optical effect Effects 0.000 claims description 7
- 108090000790 Enzymes Proteins 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 150000002993 phenylalanine derivatives Chemical group 0.000 claims description 5
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 4
- 125000002252 acyl group Chemical group 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 3
- 230000002255 enzymatic effect Effects 0.000 claims description 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 238000006911 enzymatic reaction Methods 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 150000002994 phenylalanines Chemical class 0.000 claims 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000000203 mixture Substances 0.000 description 4
- -1 β-substituted phenylalanine Chemical class 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 108090000604 Hydrolases Proteins 0.000 description 3
- 102000004157 Hydrolases Human genes 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- DQLHSFUMICQIMB-VIFPVBQESA-N (2s)-2-amino-3-(4-methylphenyl)propanoic acid Chemical compound CC1=CC=C(C[C@H](N)C(O)=O)C=C1 DQLHSFUMICQIMB-VIFPVBQESA-N 0.000 description 2
- AWKDBHFQJATNBQ-JTQLQIEISA-N (2s)-2-azaniumyl-3-(4-ethylphenyl)propanoate Chemical compound CCC1=CC=C(C[C@H](N)C(O)=O)C=C1 AWKDBHFQJATNBQ-JTQLQIEISA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- NIGWMJHCCYYCSF-UHFFFAOYSA-N Fenclonine Chemical compound OC(=O)C(N)CC1=CC=C(Cl)C=C1 NIGWMJHCCYYCSF-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 2
- 229960005190 phenylalanine Drugs 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- AWKDBHFQJATNBQ-UHFFFAOYSA-N 2-azaniumyl-3-(4-ethylphenyl)propanoate Chemical compound CCC1=CC=C(CC(N)C(O)=O)C=C1 AWKDBHFQJATNBQ-UHFFFAOYSA-N 0.000 description 1
- VMZCDNSFRSVYKQ-UHFFFAOYSA-N 2-phenylacetyl chloride Chemical compound ClC(=O)CC1=CC=CC=C1 VMZCDNSFRSVYKQ-UHFFFAOYSA-N 0.000 description 1
- INWFAPOVRXATBG-UHFFFAOYSA-N 3-(4-chlorophenyl)-2-[(2-phenylacetyl)amino]propanoic acid Chemical compound C=1C=CC=CC=1CC(=O)NC(C(=O)O)CC1=CC=C(Cl)C=C1 INWFAPOVRXATBG-UHFFFAOYSA-N 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 108010008292 L-Amino Acid Oxidase Proteins 0.000 description 1
- 102000007070 L-amino-acid oxidase Human genes 0.000 description 1
- 150000008547 L-phenylalanines Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229960003424 phenylacetic acid Drugs 0.000 description 1
- 239000003279 phenylacetic acid Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Description
Vynález se týká způsobu dělení optických isomerů derivátů fenylalaninu substituovaných v p-poloze. Tyto deriváty fenylalaninu jsou součástí syntetických peptidů, které mohou sloužit např. jako selektivně natriureticky působící látky a pro tento účel je nutno je připravit v opticky jednotné fůrmě.The invention relates to a process for resolving the optical isomers of phenylalanine derivatives substituted in the β-position. These phenylalanine derivatives are part of synthetic peptides, which can serve, for example, as selectively natriuretically acting substances and must be prepared in optically uniform form for this purpose.
Již dříve bylo zjištěno, že pomocí penicilin-amidohydrolázy (E. C. 3.5.1.11.) je možno odštěpit acylovou skupinu z L-formy aminokyseliny (Lucente 6., Romeo A., Rosel S.: Experientie 2i, 317 (1965); Sovětské a.o. 487940; Britský patent 1 369 462; čsl. a.o. 209 633 a Vojtíšek V., Slezák J.: Folia Microbiologica 20. 224 (1975); Simek P. e kol.: Collect. Czech. Chem. Commun. 46. 2 263 (1981). Dále bylo zjištěno, že speciřita enzymu není zcela absolutní a že i D-forma aminokyseliny je uvolňována z acylovaného derivátu. Pro deriváty fenylalaninu substituované v p-poloze však tato metoda enzymatického štěpení nebyla dosud ověřena.It has previously been found that penicillin amide hydrolase (EC 3.5.1.11) can be used to cleave the acyl group from the L-form of the amino acid (Lucente 6, Romeo A., Rosel S .: Experientie 2i, 317 (1965); British Patent 1 369 462, Czechoslovakia 209 633 and Vojtíšek V., Slezák J .: Folia Microbiologica 20, 224 (1975), Simek P. et al .: Collect. Furthermore, it has been found that the specificity of the enzyme is not absolutely absolute and that the D-form of the amino acid is also released from the acylated derivative, but for the β-substituted phenylalanine derivatives this enzymatic cleavage method has not yet been verified.
Předmětem vynálezu je způsob enzymatického dělení optických isomerů derivátů fenylalaninu substituovaných v p-poloze obecného vzorce (I),The present invention provides a method for the enzymatic resolution of the optical isomers of phenylalanine derivatives substituted in the β-position of formula (I),
XCH„-CH-COOH 2 IXCH 2 -CH-COOH 2 I
NH„ (I), kde X je alkyl obsahující 1 až 4 atomy uhlíku nebo halogen, jehož podstatou je, Se D,L-N-fenylacetylderivát fenylalaninu, zejména D,L-N-fenylacetyl-p-ethylfenylalanin, se inkubuj s enzymy s penicilinamidohydrolázovou aktivitou, s výhodou a jejich nerozpustnými formami, a to diskontlnuálním nebo kontinuálním způsobem v rozmezí teplot 15 až 45 °C, při hodnotách pH 7,0 až 8,5, s výhodou 7,6 až 7,8, a vzniklá směs derivátu L-fenylalaninu a D-N-fenyl228431 acetylderivátu fenylalaninu, zejména L-p-ethylfenylelanin a D-N-fenylacetyl-p-ethylfenylalanin, ae děli, s výhodou pomocí měniče iontů. Enzymovou reakci je výhodné vzhledem k optimálnímu složení produktu zastavit, když je dosaženo konverze, při které ještě nedochází ke štěpení acylu z D-formy aminokyseliny. Postup využívající penioilinamidohydrolázy (E.C. 3.5.1.11) nebo nerozpustné formy tohoto enzymu, např. enzymu zakotveného na buňkách Β» megaterium (Čs. AO č. 208 931), navzájem vázaných buněk E. coli (čs. AO č. 203 607) majících zachovanou pěnicilinamidohydralézovou aktivitu, zesítěných a permeabilizovaných produkčních buněk mikroorganismů (čs. AO č. 201 621) nebo agregovaných buněk (čs. AO č. 197 101) je zvláště výhodný z hlediska snadnosti izolace produktu a možnosti práce v kolonovém uspořádání. Pro získání opticky jednotného produktu je nezbytné sledovat průběh reakce vhodnou metodou např. kapalinovou nebo plynovou chromatografii a reakci zastavit při vhodném stupni konverze, s výhodou 50 %, nebot jinak dojde k postupnému odštěpení acylu i z D-formy substrátu.NH '(I), wherein X is C1 -C4 alkyl or halogen, wherein the D, LN-phenylacetyl phenylalanine derivative, in particular D, LN-phenylacetyl-p-ethylphenylalanine, is incubated with enzymes having penicillin amide hydrolase activity, preferably and their insoluble forms, in a batchwise or continuous manner, at a temperature range of 15 to 45 ° C, at pH values of 7.0 to 8.5, preferably 7.6 to 7.8, and the resulting mixture of L-phenylalanine derivative and DN-phenyl228431 of the phenylalanine acetylderivative, in particular Lp-ethylphenylelanine and DN-phenylacetyl-p-ethylphenylalanine, and are separated, preferably by means of an ion exchanger. Due to the optimum composition of the product, it is advantageous to stop the enzyme reaction when a conversion is achieved which still does not cleave the acyl from the D-form of the amino acid. Procedure using penioillin amide hydrolase (EC 3.5.1.11) or insoluble forms of this enzyme, eg enzy »megaterium cell-anchored enzyme (MS AO No. 208 931), bound E. coli cells (MS AO No. 203 607) having the retained foamyilinamidohydralysis activity, cross-linked and permeabilized production cells of microorganisms (No. AO No. 201 621) or aggregated cells (No. AO No. 197 101) is particularly advantageous in terms of product ease of isolation and column capability. In order to obtain an optically uniform product, it is necessary to monitor the progress of the reaction by a suitable method, for example liquid or gas chromatography, and to stop the reaction at a suitable degree of conversion, preferably 50%, otherwise the acyl is gradually cleaved from the D-form.
Způsob dělení optických antipodů je déle objasněn v příkladech provedení:The method of splitting optical antipodes is explained in the following examples:
Příklad 1Example 1
L-p-ethylfenylalaninL-p-ethylphenylalanine
K suspenzi D,L-p-ethylfenylalaninu (2 g) v 214 NaOH (7 ml) byl při 10 °C po částech během 30 min. přidáván fenylacetylchlorid (3 ml) a další 214 NaOH, tak aby pH směsi bylo 12. Poté byla suspenze míchána ještě 2 h při teplotě místnosti. Reakční směs byla okyselena koncentrovanou kyselinou solnou na pH 2 a uložena přes noc do lednice. Produkt byl odsát, promyt vodou, vysušen a překrystálovén z 30% ethanolu. Bylo získáno 2,65 g (82 %) látky o t. t.To a suspension of D, L-p-ethylphenylalanine (2 g) in 214 NaOH (7 mL) was portionwise at 10 ° C over 30 min. Phenylacetyl chloride (3 mL) was added and another 214 NaOH was added to bring the pH of the mixture to 12. The suspension was then stirred at room temperature for 2 h. The reaction mixture was acidified with concentrated hydrochloric acid to pH 2 and stored in the refrigerator overnight. The product was aspirated, washed with water, dried and recrystallized from 30% ethanol. 2.65 g (82%) of m.p.
146 až 149 °C.Mp 146-149 ° C.
Rp 0,93 (S 1), 0,50 (S 2), 0,86 (S 3), 0,61 (S 4). Rp 0.93 (S 1), 0.50 (S 2), 0.86 (S 3), 0.61 (S 4).
Pro C,9H2)N03 (311,4) vypočteno: 73,29 % C, 6,80 % H, 4,50 % N;For C 19 H 21 NO 3 (311.4) calculated: 73.29% C, 6.80% H, 4.50% N;
nalezeno: 72,98 % C, 6,67 % H, 4,32 % N.Found:% C, 72.98;% H, 6.67;% N, 4.32.
Vzniklý meziprodukt (fenylacetyl-DL-p-éthylfenylalanin 1,1 g) byl suspendován ve vodě (40 ml) a pH bylo upraveno na hodnotu 7,5 přídavkem 0,1 14 NaOH (3,1 ml). K vzniklému rozto-r ku byl přidán 0,2 14 fosfátový pufr (13 ml) o pH 7,5 a navzájem vázané buňky E. coli získané podle čs. AO č. 203 607 v množství 1 g a směs byla míchána při 40 °C.The resulting intermediate (phenylacetyl-DL-p-ethylphenylalanine 1.1 g) was suspended in water (40 mL) and the pH was adjusted to 7.5 by addition of 0.1 14 NaOH (3.1 mL). To the resulting solution was added 0.214 phosphate buffer (13 ml) at pH 7.5 and the bound E. coli cells obtained according to U.S. Pat. AO No. 203 607 in an amount of 1 g and the mixture was stirred at 40 ° C.
Pomocí kapalinové chromatografie byl sledován průběh štěpení MeOH-0,05% kyselina trifluoroctová 80:20): hodnoty k': kyselina fenyloctová - 1,19, fenylacetyl-p-ethylfenylalanin - 2,11, p-ethylfenylalanin - 2,84. Po 3 h byla reakční směs zfiltrována, okyselena 114 HG1 (10 ml), zfiltrována a nanesena na sloupec sulfonátového latexu (60 ml). Po promytí vodou byl produkt eluován 15% pyridinem a odpařen. Bylo získáno 234 mg (68,5 %) L-p-ethylfenylalaninu dle tenkovrstvé chromatografie ve čtyřech rozpouštědlových systémech a dle elektroforézy při dvou rozdílných pH shodného se standardem. Optická čistota zjištěná pomocí vysokotlaké kapalinové chromatografie s chirální mobilní fází (0,008 mol.l-' L-fenylalanin a 0,004 mol.l-' CuSO^ - methanol; (55:45) byla >99% a tato hodnota byla potvrzena i inkubací vzorku s oxidázou L-aminokyselin. Produkt byl překrystalován z 1M HC1; t. t.The progress of the cleavage of MeOH-0.05% trifluoroacetic acid (80:20) was monitored by liquid chromatography: k-values: phenylacetic acid - 1.19, phenylacetyl-p-ethylphenylalanine - 2.11, p-ethylphenylalanine - 2.84. After 3 h, the reaction mixture was filtered, acidified with 114 HG1 (10 mL), filtered, and loaded onto a sulfonate latex column (60 mL). After washing with water, the product was eluted with 15% pyridine and evaporated. 234 mg (68.5%) of Lp-ethylphenylalanine was obtained by thin-layer chromatography in four solvent systems and by electrophoresis at two different pHs consistent with the standard. The optical purity determined by high pressure liquid chromatography with a chiral mobile phase (0.008 mol.l - L-phenylalanine and 0.004 mol.l - CuSO4-methanol; (55:45) was > 99% and this value was confirmed by incubation of the sample. with L-amino acid oxidase The product was recrystallized from 1M HCl;
206 až 208 °C, - 23,9° (c 0,12; voda). Literatura (Zhuze A. L., Jošt K., Kasafírek E.,206 DEG -208 DEG C., -23.9 DEG (c 0.12, water). Literature (Zhuze A. L., Jošt K., Kasafírek E.,
Sudinger J.: Collect. Czech. Chem. Gommun. 29. 2 648: 1964) udává {«] -23,1° (c 0,12; voda). ® >Sudinger J .: Collect. Czech. Chem. Gommun. 29, 2648 (1964)), [.alpha.] D @ 23 = -23.1 DEG (c 0.12; water). ®>
Příklad 2Example 2
L-p-me thylfenylalaninL-p-Methylphenylalanine
Fenylacetyl-D,L-p-methylfenylalanin byl inkubován stejným způsobem jako v příkladu 1, s výjimkou toho,, že byl použit enzym zakotvený na buňkách Bacillus megaterium (čs. AO δ. 20Θ 931). Po izolaci byl získán ve výtěžku 65 % čistý L-p-methylfenylalanin shodný svými vlastnostmi se standardem (Zhuze A. L. a spol.: Gollect. Czech. Chem. Commun. 29. 2 648 /1964/). Optická čistota byla ověřena stejným způsobem jako v příkladu 1.Phenylacetyl-D, L-p-methylphenylalanine was incubated in the same manner as in Example 1, except that an enzyme anchored on Bacillus megaterium cells (MS AO δ. 20-931) was used. After isolation, pure L-p-methylphenylalanine was obtained in a yield of 65% identical to that of the standard (Zhuze A. L. et al .: Gollect. Czech. Chem. Commun. 29, 2648 (1964)). The optical purity was verified in the same manner as in Example 1.
Příklad 3Example 3
L-p-chlorfenylalaninL-p-chlorophenylalanine
Fenylacetyl-D,L-p-chlorfenylalanin byl inkubován jako v příkladu 1 s výjimkou toho, že bylo použito zesitěných a permeabilizovaných buněk (čs. AQ č. 201 621). Obvyklým zpracováním byl získán L-p-chlorfenylalanin ve výtěžku 52 %, jehož optická čistota byla ověřena stejně jako v příkladu 1.Phenylacetyl-D, L-p-chlorophenylalanine was incubated as in Example 1 except that cross-linked and permeabilized cells were used (ref. AQ No. 201 621). Conventional work-up gave L-p-chlorophenylalanine in 52% yield, the optical purity of which was verified as in Example 1.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS318682A CS228431B1 (en) | 1982-05-04 | 1982-05-04 | Process for separating of optic isomers of phenylalaninederivates being substituted in p-position |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS318682A CS228431B1 (en) | 1982-05-04 | 1982-05-04 | Process for separating of optic isomers of phenylalaninederivates being substituted in p-position |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS228431B1 true CS228431B1 (en) | 1984-05-14 |
Family
ID=5371219
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS318682A CS228431B1 (en) | 1982-05-04 | 1982-05-04 | Process for separating of optic isomers of phenylalaninederivates being substituted in p-position |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS228431B1 (en) |
-
1982
- 1982-05-04 CS CS318682A patent/CS228431B1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yamada et al. | Production of L-phenylalanine from trans-cinnamic acid with Rhodotorula glutinis containing L-phenylalanine ammonia-lyase activity | |
| Robinson et al. | Porous glass as a solid support for immobilisation or affinity chromatography of enzymes | |
| RU1806201C (en) | Method of synthesis of 2-arylpropionic acid s(+)-enantiomer | |
| EP0178106B1 (en) | Enzymatic process | |
| CA1052716A (en) | Process for the enzymatic resolution of dl-phenyl glycine amide into its optically active antipodes | |
| EP0295724A2 (en) | Biosynthesis of unnatural cephalosporins | |
| US4389488A (en) | Process for the enzymatic preparation of L-2-amino-4-methylphosphinobutyric acid | |
| US4389489A (en) | Optically pure heterocyclic aminoacid compounds, a process for their use for the synthesis of medicaments | |
| US5756800A (en) | Process for the enzymatic resolution of 2-amino-4-methyl-phosphinobutyric acid derivatives | |
| US3880713A (en) | Cephalosporin compounds | |
| RU2270869C2 (en) | Method for preparing l-amino acids from racemic n-acetyl-d,l-derivatives by enzymatic cleavage | |
| CS228431B1 (en) | Process for separating of optic isomers of phenylalaninederivates being substituted in p-position | |
| Itoh et al. | Application of inverse substrates to trypsin-catalyzed peptide synthesis | |
| Tsuji et al. | Enzymatic preparation of D-p-trimethylsilylphenylalanine | |
| EP0512848B1 (en) | Enzymatic resolution of alpha-tertiary carboxylic acid esters | |
| JPS5922516B2 (en) | Method for producing L-phenylalanine | |
| WO1991005870A1 (en) | Enzymatic production of d-amino acids | |
| JPH03187398A (en) | One process cephalosporin c amidase enzyme, gene for coding same and its expression in an appropriate host | |
| CA1187432A (en) | Microorganism and its use for the preparation of glutathione | |
| US5723321A (en) | Process for preparing D-lysine | |
| JP3078599B2 (en) | Method for producing L-3,4-dihydroxyphenylserine derivative | |
| US4579818A (en) | Biosynthesis of unnatural cephalosporins | |
| US5043279A (en) | DNA encoding a bacillus creatinase | |
| JPH02276586A (en) | Production of d-homophenylalanine | |
| Jones et al. | Rhizopterin biosynthesis in Staphylococcus epidermidis |